Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SYNOPSYS INC Director's Dealing 2025

Jun 20, 2025

29855_dirs_2025-06-20_5b5011be-1b38-4001-a88a-39c7e6b812b9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SYNOPSYS INC (SNPS)
CIK: 0000883241
Period of Report: 2025-06-18

Reporting Person: MAHONEY RICHARD S. (Chief Revenue Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-06-18 Common Stock S 4869 $471.1892 Disposed 1485 Direct
2025-06-18 Common Stock M 2949 $319.2 Acquired 4434 Direct
2025-06-18 Common Stock S 2949 $471.2728 Disposed 1485 Direct
2025-06-18 Common Stock M 1192 $354.45 Acquired 2677 Direct
2025-06-18 Common Stock S 1192 $471.1758 Disposed 1485 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-06-18 Non-Qualified Stock Option (right to buy) $319.2 M 2949 Disposed 2029-05-31 Common Stock (2949) Direct
2025-06-18 Non-Qualified Stock Option (right to buy) $354.45 M 1192 Disposed 2030-02-17 Common Stock (1192) Direct

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted September 13, 2024.

F2: Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $469.07 to $473.33. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range.

F3: Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $469.14 to $473.33. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range.

F4: 1/4 of the grant becomes exercisable on the date shown with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date.